OKYO Pharma (OKYO) Debt Ratio (2023 - 2025)
OKYO Pharma (OKYO) reported Debt Ratio of 0.04 for Q3 2025, up 6159.93% year-over-year from 0.0 in Q3 2024, and down 82.88% quarter-over-quarter from 0.23 in Q1 2025.
OKYO Pharma (OKYO) Debt Ratio (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has 3 years of Debt Ratio data on file, last reported at 0.04 in Q3 2025.
- Debt Ratio for Q3 2025 came in at 0.04, up 6159.93% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.04 (up 6159.93% YoY), and the FY2025 annual result was 0.23, changed 0.41% from the prior year.
- Debt Ratio declined to 0.04 in Q3 2025 per OKYO's latest filing, from 0.23 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.23 in Q1 2025 and troughed at 0.0 in Q3 2024.
- A 3-year average of 0.15 and a median of 0.22 in 2023 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio plunged 99.71% in 2024, then surged 6159.93% in 2025.
- A 3-year view of Debt Ratio shows it stood at 0.22 in 2023, then sank by 99.71% to 0.0 in 2024, then jumped by 6159.93% to 0.04 in 2025.
- Business Quant data shows OKYO's Debt Ratio at 0.04 in Q3 2025, 0.23 in Q1 2025, and 0.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OKYO Pharma | 240.90 Mn | 236.68 Mn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.23 |
| Sep 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.23 |
| Sep 30, 2023 | 0.22 |